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In Vivo AD Model 
Two transgenes (APP, PSEN1) Healthy Control 
• APP and PSEN1 transgenic mice 
• Isolate RNA from mouse brain and blood samples (n=3) 
• Determine differential expression levels from mRNA 
and miRNA  
Gene Expression and AD 
•  The AD brain displays altered gene expression 
patterns compared to a normal brain 
•  Other tissues including blood may also exhibit 
these expression changes 
•  Research suggests that post-transcriptional 
regulation by miRNA also plays a role in AD 
pathology.  
RNA was isolated from the 
hippocampus and blood of 
AD and control mice.  
 
 
 
mRNA was purified and 
converted to cDNA using 
an Illumina gene 
sequencing preparation 
kit.  
 
 
 
Prepared cDNA samples 
were sequenced using an 
Illumina MiSeq gene 
sequencer.  
 
 
 
Differential expression 
was evaluated via the 
Galaxy data analysis 
platform. 
RNA isolated from a 
laboratory mouse 
RNA Sequencing to Determine 
Differential Expression 
Data Analysis 
•  Sequencing quality was assessed by 
Qscore ≥ 30 on BaseSpace 
•  Differential expression was determined 
using TopHat, CuffLinks, and CuffDiff 
•  Gene-by-gene confirmations using qPCR 
Significance of miRNA Expression 
Differential Expression in AD 
vs. Normal Brain 
•  5053 transcripts differentially expressed 
in the brain 
•  Known AD-related genes differentially 
expressed in our model 
•  Analysis of changing genes not 
previously linked to AD 
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•  Previous research by our group revealed 
epigenetic modification of genes that code for 
miRNA. 
•  Gene products associated with AD are targeted 
by these miRNA. 
•  Differences in miRNA expression could shed light 
on understanding the role of epigenetics in AD 
pathology. 
 
RNA isolated from the 
hippocampus of AD and 
control mice 
miScript assay was used 
to determine expression 
of specific miRNA 
Differential expression 
analyzed via differences 
in fold change  
Converted to cDNA using 
miScript assay (Qiagen) 
to polyadenylate and add 
universal tag  
miRNA Expression Analysis 
Preliminary miRNA Data 
•  Expression changes analyzed in: Mir-17, Mir-26b, 
Mir-92, Mir-702 
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•  Consistent upregulation 
of Mir-17 in AD brain 
•  Genome-wide analysis 
could prove significant 
Application of Expression Data 
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•  Expression patterns in blood will be compared to 
those in brain 
•  If changes in brain and blood correspond for an 
AD model, altered expression in blood could be 
used as a diagnostic marker for AD 
•  Expression of miRNA may provide insight into 
mechanisms of AD development 
•  Better understanding of AD proves itself valuable 
in development of AD treatments 
